A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults

BACKGROUND: Respiratory syncytial virus (RSV) is an important cause of disease in older adults. We evaluated the safety and immunogenicity of a stabilized RSV prefusion F subunit (RSVpreF) vaccine candidate with/without adjuvant in adults aged 65–85 years. METHODS: Primary cohort participants were e...

Descripción completa

Detalles Bibliográficos
Autores principales: Baber, James, Arya, Mark, Moodley, Yuben, Jaques, Anna, Jiang, Qin, Swanson, Kena A, Cooper, David, Maddur, Mohan S, Loschko, Jakob, Gurtman, Alejandra, Jansen, Kathrin U, Gruber, William C, Dormitzer, Philip R, Schmoele-Thoma, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749002/
https://www.ncbi.nlm.nih.gov/pubmed/35543281
http://dx.doi.org/10.1093/infdis/jiac189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749002/
https://www.ncbi.nlm.nih.gov/pubmed/35543281
http://dx.doi.org/10.1093/infdis/jiac189

Ejemplares similares